Meanwhile, cervical cancer patients with GG in MACC1 SNP rs975263 had 5 years survival rate 0.80 (95% CI=0.45-1.00) as compared to those with AA/AG 0.82 (95% CI=0.75-0.90) with no significantly different 5 years survival rate (p=0.897, HR=1.14, 95% CI=0.15-8.54; Table 4). This evidence concerns the gene MACC1 and cervical carcinoma.